Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the successful conclusion of the eleventh Annual Genedata Partner Symposium (March 31?April 1 ...

The five youngest billionaires in the world this year, all heirs to their fortunes, collectively hold US$18.1 billion in wealth, according to Forbes’ latest annual ranking.

First VISTA Inhibitor Drug Approval By 2028 Says Kuick Research In New Research Publication. Delhi, April 02, 2025 (GLOBE ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Boehringer Laboratory Illustrative image Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to ...

France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

A research team from the University of Minnesota Medical School has identified a strong predictor of ischemic stroke and dementia, a discovery that could lead to improved patient outcomes. The ...

Cash and cash equivalents were $34.6M as of December 31, compared to $31.0M as of September 30 and $36.M as of December 31, 2023. In ...

Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...